{"entity":{"type":"insider","cik":"0001954991","url":"/insider/0001954991","json_url":"/insider/0001954991.json","name":"Herzich Paul","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2023-12-05","last":"2026-02-18","span_basis":"filed_date"},"name_variants":[{"name":"Herzich Paul","source":"filing","n_filings":7,"first_seen":"2023-12-05","last_seen":"2026-02-18"}],"transactions":[{"id":5847103,"accession":"0001193125-26-057865","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-057865","line_url":"/filing/0001193125-26-057865#line-2","is_derivative":false,"issuer_cik":"0001707502","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001707502","owner_cik":"0001954991","owner_name":"Herzich Paul","owner_display_name":"Herzich Paul","owner_url":"/insider/0001954991","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3616.0,"shares_display":"3,616","price_per_share":5.8233,"price_display":"5.82","price_state":"stated","total_value":21057.0528,"total_display":"21,057.05","total_whole":"21,057","shares_owned_after":72638.0,"shares_owned_after_display":"72,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-18","scope":"insider"},{"id":5770456,"accession":"0001193125-26-041506","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-041506","line_url":"/filing/0001193125-26-041506#line-1","is_derivative":false,"issuer_cik":"0001707502","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001707502","owner_cik":"0001954991","owner_name":"Herzich Paul","owner_display_name":"Herzich Paul","owner_url":"/insider/0001954991","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10905.0,"shares_display":"10,905","price_per_share":6.4419,"price_display":"6.44","price_state":"stated","total_value":70248.9195,"total_display":"70,248.92","total_whole":"70,249","shares_owned_after":69067.0,"shares_owned_after_display":"69,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-06","scope":"insider"},{"id":5943303,"accession":"0001193125-26-034076","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-034076","line_url":"/filing/0001193125-26-034076#line-3","is_derivative":false,"issuer_cik":"0001707502","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001707502","owner_cik":"0001954991","owner_name":"Herzich Paul","owner_display_name":"Herzich Paul","owner_url":"/insider/0001954991","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26250.0,"shares_display":"26,250","price_per_share":6.4369,"price_display":"6.44","price_state":"stated","total_value":168968.625,"total_display":"168,968.62","total_whole":"168,969","shares_owned_after":79972.0,"shares_owned_after_display":"79,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-02","scope":"insider"},{"id":5069783,"accession":"0001193125-25-308103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-308103","line_url":"/filing/0001193125-25-308103#line-2","is_derivative":false,"issuer_cik":"0001707502","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001707502","owner_cik":"0001954991","owner_name":"Herzich Paul","owner_display_name":"Herzich Paul","owner_url":"/insider/0001954991","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2701.0,"shares_display":"2,701","price_per_share":5.11,"price_display":"5.11","price_state":"stated","total_value":13802.11,"total_display":"13,802.11","total_whole":"13,802","shares_owned_after":26622.0,"shares_owned_after_display":"26,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-04","scope":"insider"},{"id":4659657,"accession":"0000950170-25-022201","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-022201","line_url":"/filing/0000950170-25-022201#line-2","is_derivative":false,"issuer_cik":"0001707502","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001707502","owner_cik":"0001954991","owner_name":"Herzich Paul","owner_display_name":"Herzich Paul","owner_url":"/insider/0001954991","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2688.0,"shares_display":"2,688","price_per_share":3.96,"price_display":"3.96","price_state":"stated","total_value":10644.48,"total_display":"10,644.48","total_whole":"10,644","shares_owned_after":18388.0,"shares_owned_after_display":"18,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-18","scope":"insider"},{"id":2429911,"accession":"0000950170-24-133317","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-133317","line_url":"/filing/0000950170-24-133317#line-2","is_derivative":false,"issuer_cik":"0001707502","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001707502","owner_cik":"0001954991","owner_name":"Herzich Paul","owner_display_name":"Herzich Paul","owner_url":"/insider/0001954991","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2777.0,"shares_display":"2,777","price_per_share":5.5998,"price_display":"5.60","price_state":"stated","total_value":15550.6446,"total_display":"15,550.64","total_whole":"15,551","shares_owned_after":12182.0,"shares_owned_after_display":"12,182","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-03","filed_date":"2024-12-04","scope":"insider"},{"id":8040415,"accession":"0000950170-23-068065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-068065","line_url":"/filing/0000950170-23-068065#line-2","is_derivative":false,"issuer_cik":"0001707502","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001707502","owner_cik":"0001954991","owner_name":"Herzich Paul","owner_display_name":"Herzich Paul","owner_url":"/insider/0001954991","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2968.0,"shares_display":"2,968","price_per_share":2.7737,"price_display":"2.77","price_state":"stated","total_value":8232.3416,"total_display":"8,232.34","total_whole":"8,232","shares_owned_after":4270.0,"shares_owned_after_display":"4,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001707502","name":"Solid Biosciences Inc.","url":"/issuer/0001707502","role":"Officer (Chief Technology Officer)","n_filings":7,"first_seen":"2023-12-05","last_seen":"2026-02-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001954991","retrieved_at":"2026-08-23T09:05:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}